RE: Still no buying19 Dec 2022 11:55
London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women's health announces today the grant of a share option under the Company share option scheme.
A share option over 150,000 ordinary shares has been granted to Stella Panu in recognition of her recent appointment as Non-executive Director of the Company.
The structure of the share option is identical to the share options scheme announced on 6 September 2022.
The options detailed in the schedule below are exercisable only under market conditions that demonstrate growth in the Company's market capitalisation. Band 1 options vest only after the Company's share price has maintained a 20 Day VWAP (Volume Weighted Average Price) of 25p, Band 2 options vest only after the share price has maintained a 20 Day VWAP of 30p and Band 3 Options vest only after the share price has maintained a 20 Day VWAP of 40p within 2 years of the options being issued. If the price has not reached these price targets by 11 October 2024, the options will lapse; if they meet the criteria, the options can be exercised at any date to 11 October 2032 with an exercise price of 12p.
Directors:
Band 1 Options
Band 2 Options
Band 3 Options
Stella Panu
-
75,000
75,000